{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:04:10Z","timestamp":1772136250829,"version":"3.50.1"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"publisher","award":["P1-0245"],"award-info":[{"award-number":["P1-0245"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"publisher","award":["J3-4504"],"award-info":[{"award-number":["J3-4504"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"publisher","award":["J3-2526"],"award-info":[{"award-number":["J3-2526"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"publisher","award":["NC-0023"],"award-info":[{"award-number":["NC-0023"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"publisher","award":["Z3-2649"],"award-info":[{"award-number":["Z3-2649"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"publisher","award":["Z3-1869"],"award-info":[{"award-number":["Z3-1869"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"publisher","award":["Z3-4510"],"award-info":[{"award-number":["Z3-4510"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"publisher","award":["P1-0390"],"award-info":[{"award-number":["P1-0390"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"publisher","award":["P2-0209"],"award-info":[{"award-number":["P2-0209"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Young Researcher","award":["10040137"],"award-info":[{"award-number":["10040137"]}]},{"name":"Young Researcher","award":["10040147"],"award-info":[{"award-number":["10040147"]}]},{"name":"European Program of Cross-Border Cooperation for Slovenia-Italy Interreg TRANS-GLIOMA"},{"name":"European Union\u2019s Horizon project Twinning","award":["101079113"],"award-info":[{"award-number":["101079113"]}]},{"name":"Marie Sklodowska-Curie Innovative Training Network 2020","award":["956394"],"award-info":[{"award-number":["956394"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Glioblastoma (GB) is one of the most lethal solid tumors in humans, with an average patient life expectancy of 15 months and a 5-year survival rate of 5%\u201310%. GB is still uncurable due to tumor heterogeneity and invasive nature as well as therapy-resistant cancer cells. Centralized biobanks with clinical data and corresponding biological material of GB patients facilitate the development of new treatment approaches and the search for clinically relevant biomarkers, with the goal of improving outcomes for GB patients. The aim of this study was firstly to establish a Slovenian translation platform, GlioBank, and secondly to demonstrate its utility through the identification of molecular signatures associated with GB progression and patient survival.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>GlioBank contains tissue samples and corresponding tumor models as well as clinical data from patients diagnosed with glioma, with a focus on GB. Primary GB cells, glioblastoma stem cells (GSCs), and organoids have been established from fresh tumor biopsies. We performed expression analyses of genes associated with GB progression and bioinformatics analyses of available clinical and research data obtained from a subset of 91 GB patients. qPCR was performed to determine the expression of genes associated with therapy resistance and cancer cell invasion, including markers of different GB subtypes, GSCs, epithelial-to-mesenchymal transition, and immunomodulation\/chemokine signaling in tumor tissues and corresponding cellular models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>GlioBank contains biological material and research, and clinical data collected in the SciNote electronic laboratory notebook. To date, more than 240 glioma tissue samples have been collected and stored in GlioBank, most of which are GB tissues (205) and were further processed to establish primary GB cells (n\u2005=\u200564), GSCs (n\u2005=\u200514), and GB organoids (n\u2005=\u200517). Corresponding blood plasma (n\u2005=\u2005103) and peripheral blood mononuclear cells (n\u2005=\u2005101) are also stored. GB tumors were classified into 4 different subtypes that differed regarding patient survival; the mixed subtype exhibited the longest patient survival. High DAB2, S100A4, and STAT3 expression were associated with poor overall patient survival, and DAB2 was found to be an independent prognostic marker for GB survival. We analyzed the molecular signatures between different tumor regions (core vs. rim). STMN4, ERBB3, and ACSBG1 were upregulated in the tumor rim, suggesting that these genes are associated with the invasive nature of GB.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>GlioBank is a centralized biobank that has been built by a multidisciplinary network with the aim of facilitating disease-oriented basic and clinical research. The advantages of GlioBank include the molecular characterization of GB based on targeted gene expression, the availability of diverse cellular models (eg, GB cells and organoids), and a large number of patient-matched tumor core and rim samples, all with accompanying molecular and clinical data. We report here for the first time an association between DAB2 expression and low overall survival in GB patients, indicative of a prognostic value of DAB2.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/noajnl\/vdaf015","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T16:02:55Z","timestamp":1737561775000},"source":"Crossref","is-referenced-by-count":6,"title":["The Slovenian translational platform GlioBank for brain tumor research: Identification of molecular signatures of glioblastoma progression"],"prefix":"10.1093","volume":"7","author":[{"given":"Metka","family":"Novak","sequence":"first","affiliation":[{"name":"Department of Genetic Toxicology and Cancer Biology, National Institute of Biology , Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernarda","family":"Majc","sequence":"additional","affiliation":[{"name":"Department of Genetic Toxicology and Cancer Biology, National Institute of Biology , Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Malavolta","sequence":"additional","affiliation":[{"name":"Department of Genetic Toxicology and Cancer Biology, National Institute of Biology , Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrej","family":"Por\u010dnik","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Medical Centre Ljubljana , Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jernej","family":"Mlakar","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Faculty of Medicine, University of Ljubljana , Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matja\u017e","family":"Hren","sequence":"additional","affiliation":[{"name":"Biosistemika, d.o.o ., Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anamarija","family":"Habi\u010d","sequence":"additional","affiliation":[{"name":"Jo\u017eef Stefan International Postgraduate School , Ljubljana ,","place":["Slovenia"]},{"name":"Department of Genetic Toxicology and Cancer Biology, National Institute of Biology , Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateja","family":"Mlinar","sequence":"additional","affiliation":[{"name":"Department of Genetic Toxicology and Cancer Biology, National Institute of Biology , Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Jov\u010devska","sequence":"additional","affiliation":[{"name":"Medical Centre for Molecular Biology, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana , Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neja","family":"\u0160amec","sequence":"additional","affiliation":[{"name":"Medical Centre for Molecular Biology, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana , Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alja","family":"Zottel","sequence":"additional","affiliation":[{"name":"Medical Centre for Molecular Biology, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana , Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Skoblar Vidmar","sequence":"additional","affiliation":[{"name":"Division of Radiotherapy, Institute of Oncology Ljubljana , Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Vipotnik Vesnaver","sequence":"additional","affiliation":[{"name":"Institute of Radiology, University Medical Centre Ljubljana , Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrej","family":"Zupan","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Faculty of Medicine, University of Ljubljana , Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alenka","family":"Matja\u0161i\u010d","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Faculty of Medicine, University of Ljubljana , Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa\u0161a","family":"Trkov Bobnar","sequence":"additional","affiliation":[{"name":"Biosistemika, d.o.o ., Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dejan","family":"Georgiev","sequence":"additional","affiliation":[{"name":"Faculty of Computer and Information Science, University of Ljubljana , Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksander","family":"Sadikov","sequence":"additional","affiliation":[{"name":"Faculty of Computer and Information Science, University of Ljubljana , Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Bo\u0161njak","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Medical Centre Ljubljana , Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borut","family":"Prestor","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Medical Centre Ljubljana , Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radovan","family":"Komel","sequence":"additional","affiliation":[{"name":"Medical Centre for Molecular Biology, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana , Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Lah Turn\u0161ek","sequence":"additional","affiliation":[{"name":"Department of Genetic Toxicology and Cancer Biology, National Institute of Biology , Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0247-5811","authenticated-orcid":false,"given":"Barbara","family":"Breznik","sequence":"additional","affiliation":[{"name":"Department of Genetic Toxicology and Cancer Biology, National Institute of Biology , Ljubljana ,","place":["Slovenia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"issue":"8","key":"2025021713323433200_CIT0001","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/s41416-019-0404-y","article-title":"Cell lines and immune classification of glioblastoma define patient\u2019s prognosis","volume":"120","author":"Klopfenstein","year":"2019","journal-title":"Br J Cancer."},{"key":"2025021713323433200_CIT0002","doi-asserted-by":"crossref","first-page":"832742","DOI":"10.3389\/fgene.2022.832742","article-title":"Gene expression profiling of glioblastoma to recognize potential biomarker candidates","volume":"13","author":"Li","year":"2022","journal-title":"Front Genet."},{"issue":"4","key":"2025021713323433200_CIT0003","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3322\/caac.21613","article-title":"Management of glioblastoma: State of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J Clin."},{"issue":"9","key":"2025021713323433200_CIT0004","doi-asserted-by":"crossref","first-page":"1902971","DOI":"10.1002\/advs.201902971","article-title":"Advances in the knowledge of the molecular biology of glioblastoma and its impact in patient diagnosis, stratification, and treatment","volume":"7","author":"Delgado-Mart\u00edn","year":"2020","journal-title":"Adv Sci."},{"issue":"5","key":"2025021713323433200_CIT0005","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2353\/ajpath.2007.070011","article-title":"Genetic pathways to primary and secondary glioblastoma","volume":"170","author":"Ohgaki","year":"2007","journal-title":"Am J Pathol."},{"key":"2025021713323433200_CIT0006","doi-asserted-by":"crossref","first-page":"105780","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol Res."},{"issue":"21","key":"2025021713323433200_CIT0007","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1200\/JCO.2017.73.0119","article-title":"Adult glioblastoma","volume":"35","author":"Alexander","year":"2017","journal-title":"J Clin Oncol."},{"issue":"5","key":"2025021713323433200_CIT0008","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"issue":"10","key":"2025021713323433200_CIT0009","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med."},{"issue":"7","key":"2025021713323433200_CIT0010","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/annonc\/mdx169","article-title":"Intratumoral heterogeneity: Pathways to treatment resistance and relapse in human glioblastoma","volume":"28","author":"Qazi","year":"2017","journal-title":"Ann Oncol."},{"issue":"3","key":"2025021713323433200_CIT0011","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3390\/cells10030484","article-title":"The many facets of therapy resistance and tumor recurrence in glioblastoma","volume":"10","author":"Goenka","year":"2021","journal-title":"Cells"},{"issue":"1","key":"2025021713323433200_CIT0012","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3390\/ijms22010351","article-title":"Molecular mechanisms of treatment resistance in glioblastoma","volume":"22","author":"Ou","year":"2020","journal-title":"Int J Mol Sci."},{"issue":"4","key":"2025021713323433200_CIT0013","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/cancers11040469","article-title":"Pathological and molecular features of glioblastoma and its peritumoral tissue","volume":"11","author":"D\u2019Alessio","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"9","key":"2025021713323433200_CIT0014","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41568-022-00486-x","article-title":"Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity","volume":"22","author":"Gimple","year":"2022","journal-title":"Nat Rev Cancer."},{"issue":"4","key":"2025021713323433200_CIT0015","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/onc.2016.230","article-title":"Differential propagation of stroma and cancer stem cells dictates tumorigenesis and multipotency","volume":"36","author":"Behnan","year":"2017","journal-title":"Oncogene."},{"issue":"3","key":"2025021713323433200_CIT0016","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","article-title":"Mesenchymal differentiation mediated by NF-\u03baB promotes radiation resistance in glioblastoma","volume":"24","author":"Bhat","year":"2013","journal-title":"Cancer Cell"},{"issue":"7","key":"2025021713323433200_CIT0017","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.celrep.2019.01.076","article-title":"Phenotypic plasticity of invasive edge glioma stem-like cells in response to ionizing radiation","volume":"26","author":"Minata","year":"2019","journal-title":"Cell Rep"},{"issue":"10","key":"2025021713323433200_CIT0018","doi-asserted-by":"crossref","first-page":"118782","DOI":"10.1016\/j.bbamcr.2020.118782","article-title":"Epithelial-to-mesenchymal transition as the driver of changing carcinoma and glioblastoma microenvironment","volume":"1867","author":"Majc","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Res."},{"issue":"12","key":"2025021713323433200_CIT0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21124199","article-title":"CCR5-mediated signaling is involved in invasion of glioblastoma cells in its microenvironment","volume":"21","author":"Novak","year":"2020","journal-title":"Int J Mol Sci ."},{"issue":"5","key":"2025021713323433200_CIT0020","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.celrep.2017.10.030","article-title":"Single-cell RNA-seq analysis of infiltrating neoplastic cells at the migrating front of human glioblastoma","volume":"21","author":"Darmanis","year":"2017","journal-title":"Cell Rep"},{"issue":"5","key":"2025021713323433200_CIT0021","doi-asserted-by":"crossref","first-page":"112472","DOI":"10.1016\/j.celrep.2023.112472","article-title":"Glioblastoma cell fate is differentially regulated by the microenvironments of the tumor bulk and infiltrative margin","volume":"42","author":"Garcia-Diaz","year":"2023","journal-title":"Cell Rep"},{"issue":"4","key":"2025021713323433200_CIT0022","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1158\/1078-0432.CCR-21-2750","article-title":"Glioblastoma clinical trials: Current landscape and opportunities for improvement","volume":"28","author":"Bagley","year":"2022","journal-title":"Clin Cancer Res."},{"issue":"1","key":"2025021713323433200_CIT0023","first-page":"31","article-title":"Driving innovation through collaboration: Development of clinical annotation datasets for brain cancer biobanking","volume":"7","author":"Gedye","year":"2020","journal-title":"Neurooncol. Pract.."},{"issue":"17","key":"2025021713323433200_CIT0024","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.3390\/molecules26175141","article-title":"TRIM28 selective nanobody reduces glioblastoma stem cell invasion","volume":"26","author":"Por\u010dnik","year":"2021","journal-title":"Molecules."},{"issue":"11","key":"2025021713323433200_CIT0025","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.3390\/ijms18112452","article-title":"The invasive region of glioblastoma defined by 5ALA guided surgery has an altered cancer stem cell marker profile compared to central tumour","volume":"18","author":"Smith","year":"2017","journal-title":"Int J Mol Sci ."},{"issue":"1","key":"2025021713323433200_CIT0026","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s42003-022-03402-z","article-title":"Infiltrating natural killer cells bind, lyse and increase chemotherapy efficacy in glioblastoma stem-like tumorospheres","volume":"5","author":"Breznik","year":"2022","journal-title":"Commun Biol."},{"issue":"3","key":"2025021713323433200_CIT0027","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.3390\/ijms23031784","article-title":"Upregulation of Cathepsin X in glioblastoma: Interplay with \u03b3-Enolase and the effects of selective Cathepsin X inhibitors","volume":"23","author":"Majc","year":"2022","journal-title":"Int J Mol Sci ."},{"issue":"3","key":"2025021713323433200_CIT0028","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/cancers15030573","article-title":"Anti-vimentin nanobody decreases glioblastoma cell invasion in vitro and in vivo","volume":"15","author":"Zottel","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2025021713323433200_CIT0029","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","article-title":"A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity","volume":"180","author":"Jacob","year":"2020","journal-title":"Cell."},{"issue":"12","key":"2025021713323433200_CIT0030","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1038\/s41596-020-0402-9","article-title":"Generation and biobanking of patient-derived glioblastoma organoids and their application in CAR T cell testing","volume":"15","author":"Jacob","year":"2020","journal-title":"Nat Protoc"},{"issue":"9","key":"2025021713323433200_CIT0031","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110604","article-title":"Patient-derived tumor organoids mimic treatment-induced DNA damage response in glioblastoma","volume":"27","author":"Majc","year":"2024","journal-title":"iScience"},{"issue":"1","key":"2025021713323433200_CIT0032","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12859-017-1688-7","article-title":"quantGenius: implementation of a decision support system for qPCR-based gene quantification","volume":"18","author":"Baebler","year":"2017","journal-title":"BMC Bioinf."},{"key":"2025021713323433200_CIT0033","author":"SciNote"},{"key":"2025021713323433200_CIT0034","author":"Puchalski"},{"issue":"5","key":"2025021713323433200_CIT0035","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10897-010-9305-1","article-title":"Biobanks: importance, implications and opportunities for genetic counselors","volume":"19","author":"Hawkins","year":"2010","journal-title":"J Genet Couns."},{"key":"2025021713323433200_CIT0036"},{"key":"2025021713323433200_CIT0037","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/B978-0-12-801899-6.00002-4","article-title":"The importance of biobanks in epigenetic studies","volume-title":"Epigenetic Biomarkers and Diagnostics","author":"Peir\u00f3-Chova","year":"2016"},{"issue":"8","key":"2025021713323433200_CIT0038","doi-asserted-by":"crossref","first-page":"e71070","DOI":"10.1371\/journal.pone.0071070","article-title":"Establishment and characterization of primary glioblastoma cell lines from fresh and frozen material: A detailed comparison","volume":"8","author":"Mullins","year":"2013","journal-title":"PLoS One."},{"issue":"2","key":"2025021713323433200_CIT0039","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/iub.1964","article-title":"In vitro neurosphere formation correlates with poor survival in glioma","volume":"71","author":"Jayakrishnan P","year":"2019","journal-title":"IUBMB Life."},{"key":"2025021713323433200_CIT0040","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920915302","article-title":"Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration","volume":"12","author":"Zottel","year":"2020","journal-title":"Ther Adv Med Oncol"},{"issue":"34","key":"2025021713323433200_CIT0041","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/onc.2010.215","article-title":"EMT, cancer stem cells and drug resistance: An emerging axis of evil in the war on cancer","volume":"29","author":"Singh","year":"2010","journal-title":"Oncogene."},{"issue":"11","key":"2025021713323433200_CIT0042","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/j.celrep.2016.11.056","article-title":"Clonal variation in drug and radiation response among glioma-initiating cells is linked to proneural-mesenchymal transition","volume":"17","author":"Segerman","year":"2016","journal-title":"Cell Rep"},{"issue":"19","key":"2025021713323433200_CIT0043","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1158\/0008-5472.CAN-17-1294","article-title":"S100A4 is a biomarker and regulator of glioma stem cells that is critical for mesenchymal transition in glioblastoma","volume":"77","author":"Chow","year":"2017","journal-title":"Cancer Res."},{"issue":"7120","key":"2025021713323433200_CIT0044","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature."},{"issue":"42","key":"2025021713323433200_CIT0045","doi-asserted-by":"crossref","first-page":"73219","DOI":"10.18632\/oncotarget.18016","article-title":"S100A4 in cancer progression and metastasis: A systematic review","volume":"8","author":"Fei","year":"2017","journal-title":"Oncotarget"},{"key":"2025021713323433200_CIT0046","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/978-1-4939-9030-6_22","article-title":"The multifaceted S100A4 protein in cancer and inflammation","volume":"1929","author":"Ambartsumian","year":"2019","journal-title":"Methods Mol Biol."},{"issue":"1","key":"2025021713323433200_CIT0047","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/neuonc\/now247","article-title":"GlioVis data portal for visualization and analysis of brain tumor expression datasets","volume":"19","author":"Bowman","year":"2017","journal-title":"Neuro Oncol"},{"issue":"1","key":"2025021713323433200_CIT0048","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41467-022-28372-y","article-title":"Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target","volume":"13","author":"Abdelfattah","year":"2022","journal-title":"Nat Commun."},{"issue":"1","key":"2025021713323433200_CIT0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-11614-x","article-title":"A STAT3-based gene signature stratifies glioma patients for targeted therapy","volume":"10","author":"Tan","year":"2019","journal-title":"Nat Commun."},{"key":"2025021713323433200_CIT0050","doi-asserted-by":"publisher","first-page":"963689720933241","DOI":"10.1177\/0963689720933241","article-title":"DNA methylation-based diagnostic and prognostic biomarkers for glioblastoma","volume-title":"Cell Transplant","author":"Tang","year":"2020"},{"key":"2025021713323433200_CIT0051","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/B978-0-12-821567-8.00014-2","article-title":"Targeting the molecular mechanisms of glioma stem cell resistance to chemotherapy","volume-title":"Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies","author":"Fares","year":"2021"},{"issue":"10","key":"2025021713323433200_CIT0052","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/stem.185","article-title":"STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells","volume":"27","author":"Sherry","year":"2009","journal-title":"Stem Cells."},{"issue":"1","key":"2025021713323433200_CIT0053","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/diagnostics10010054","article-title":"Disabled homolog 2 (DAB2) protein in tumor microenvironment correlates with aggressive phenotype in human urothelial carcinoma of the bladder","volume":"10","author":"Itami","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"2025021713323433200_CIT0054","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3390\/ijms24010696","article-title":"Disabled-2 (DAB2): A key regulator of anti- and pro-tumorigenic pathways","volume":"24","author":"Price","year":"2022","journal-title":"Int J Mol Sci ."},{"issue":"4","key":"2025021713323433200_CIT0055","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1172\/JCI79590","article-title":"Disabled homolog 2 controls macrophage phenotypic polarization and adipose tissue inflammation","volume":"126","author":"Adamson","year":"2016","journal-title":"J Clin Invest."},{"issue":"11","key":"2025021713323433200_CIT0056","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1158\/2159-8290.CD-20-0036","article-title":"Disabled homolog 2 controls prometastatic activity of tumor-associated macrophages","volume":"10","author":"Marigo","year":"2020","journal-title":"Cancer Discov"},{"issue":"1","key":"2025021713323433200_CIT0057","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"issue":"6190","key":"2025021713323433200_CIT0058","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science."},{"issue":"11","key":"2025021713323433200_CIT0059","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/nm.4415","article-title":"Targeting glioma stem cells through combined BMI1 and EZH2 inhibition","volume":"23","author":"Jin","year":"2017","journal-title":"Nat Med."}],"container-title":["Neuro-Oncology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/noa\/advance-article-pdf\/doi\/10.1093\/noajnl\/vdaf015\/61559820\/vdaf015.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/7\/1\/vdaf015\/61559820\/vdaf015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/7\/1\/vdaf015\/61559820\/vdaf015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T13:33:18Z","timestamp":1739799198000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/noa\/article\/doi\/10.1093\/noajnl\/vdaf015\/7972534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/noajnl\/vdaf015","relation":{},"ISSN":["2632-2498"],"issn-type":[{"value":"2632-2498","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2025,1]]},"article-number":"vdaf015"}}